---
title: "Validation of a Brief Tablet-Based Cognitive Assessment (TabCAT) for Older Adults in Uganda"
id: "medrxiv-3-adaptation-and-validation-of-brief-tablet-based-cognitive-assessment-tool-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-adaptation-and-validation-of-brief-tablet-based-cognitive-assessment-tool-in"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.21.26363152v1?rss=1"
published_at: "2026-09-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Validation of a Brief Tablet-Based Cognitive Assessment (TabCAT) for Older Adults in Uganda
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-adaptation-and-validation-of-brief-tablet-based-cognitive-assessment-tool-in
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.21.26363152v1?rss=1)
- **Published At:** 2026-09-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The Tablet-based Cognitive Assessment Tool (**TabCAT**) was translated, culturally adapted, and validated in southwestern Uganda within the Uganda Aging and Dementia Cohort Study (UADCS). - The study included 563 participants (mean age 60 ± 6.4 years; 50% female; 49% people living with HIV [**PLWH**]). - Education and literacy were limited for many participants: 51% did not complete primary school and 16% were not literate. - Four TabCAT tests were adapted through expert review and focus groups at study sites and were judged to have acceptable face and content validity locally. - Psychometric evaluation assessed floor/ceiling effects, associations with known demographic predictors (age, education), and concurrent/divergent validity against a previously validated reference-standard cognitive battery used in Uganda. - Regression-based normative Z-scores were derived adjusting for age, sex, education, urbanicity, and literacy. - Correlations between TabCAT and reference-standard tests were stronger for aligned cognitive domains (memory, executive function) than for non-aligning domains (motor), supporting construct validity. - The TabCAT Composite Score discriminated objective cognitive impairment (Jak/Bondi criteria) with good accuracy (c-statistic 0.77; 95% CI 0.72–0.81), including when analyses were restricted to PLWH. - No notable floor or ceiling effects were observed for TabCAT measures. Test scores varied with age and education as expected. - Ethical approvals were obtained from Massachusetts General Hospital IRB, Mbarara University Research Ethics Committee (MUSTREC), and the Uganda National Council for Science and Technology (UNCST). Data are available on reasonable request from the corresponding author. - Funders included the US National Institute on Aging, the Alzheimer’s Association, and The Michael J. Fox Foundation for Parkinson’s Research. One author reported unrelated honoraria; other authors declared no relevant conflicts.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=VL._Yl92D9KJo01HVD1.Hd10aDJdAJr6xdLivbK4Tzg-1790184959.601986-1.2.1.1-Bd1dk1ozzApyPUOsjODyLc4RNHMbUe7gCiD8Tt1fhkOAKwSjbxKs.8C5lfgW_j96) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.21.26363152v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) ## Error message * Unable to create CTools CSS cache directory. Check the permissions on your files directory. * Unable to create CTools CSS cache directory. Check the permissions on your files directory. Follow this preprint # Adaptation and Validation of Brief Tablet-Based Cognitive Assessment Tool in Uganda Roslyn Valdespino, Gabrielle Hromas, Chen-Pin Wang, Robert Paul, Noeline Nakasujja, Zahra Reynolds, Flavia Atwiine, Edna Tindimwebwa, Meredith Greene, Eliza Passell, Christine S. Ritchie, Susanne S. Hoeppner, Alexander C. Tsai, Janet Seeley, Amy Werry, Emi Varfaj, Sudha Seshadri, Samson Okello, Stephen Asiimwe, Deanna Saylor, Katherine L. Possin, Elena Tsoy, Mark J. Siedner, Jeremy A. Tanner doi: https://doi.org/10.64898/2026.09.21.26363152 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Roslyn Valdespino 1 Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Roslyn%2BValdespino%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Valdespino%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARoslyn%2BValdespino%2B) Gabrielle Hromas 1 Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gabrielle%2BHromas%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hromas%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGabrielle%2BHromas%2B) Chen-Pin Wang 1 Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chen-Pin%2BWang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Wang%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChen-Pin%2BWang%2B) Robert Paul 2 University of Missouri- St Louis, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Robert%2BPaul%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Paul%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARobert%2BPaul%2B) Noeline Nakasujja 3 Makerere University, Kampala, Uganda; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Noeline%2BNakasujja%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nakasujja%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANoeline%2BNakasujja%2B) Zahra Reynolds 4 Massachusetts General Hospital (MGH), Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zahra%2BReynolds%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Reynolds%20Z&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AZahra%2BReynolds%2B) Flavia Atwiine 5 Mbarara University of Science & Technology, Mbarara, Uganda; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Flavia%2BAtwiine%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Atwiine%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFlavia%2BAtwiine%2B) Edna Tindimwebwa 6 Kabwohe Clinical Research Centre, Sheema, Uganda; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Edna%2BTindimwebwa%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tindimwebwa%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEdna%2BTindimwebwa%2B) Meredith Greene 7 Indiana University School of Medicine, Indianapolis, IN, US; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Meredith%2BGreene%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Greene%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMeredith%2BGreene%2B) Eliza Passell 4 Massachusetts General Hospital (MGH), Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Eliza%2BPassell%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Passell%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEliza%2BPassell%2B) Christine S. Ritchie 4 Massachusetts General Hospital (MGH), Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christine%2BS.%2BRitchie%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ritchie%20CS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChristine%2BS.%2BRitchie%2B) Susanne S. Hoeppner 4 Massachusetts General Hospital (MGH), Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Susanne%2BS.%2BHoeppner%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hoeppner%20SS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASusanne%2BS.%2BHoeppner%2B) Alexander C. Tsai 4 Massachusetts General Hospital (MGH), Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alexander%2BC.%2BTsai%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tsai%20AC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlexander%2BC.%2BTsai%2B) Janet Seeley 8 Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Janet%2BSeeley%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Seeley%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJanet%2BSeeley%2B) Amy Werry 1 Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Amy%2BWerry%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Werry%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAmy%2BWerry%2B) Emi Varfaj 1 Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Emi%2BVarfaj%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Varfaj%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEmi%2BVarfaj%2B) Sudha Seshadri 1 Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sudha%2BSeshadri%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Seshadri%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASudha%2BSeshadri%2B) Samson Okello 9 University of North Carolina - Chapel Hill, Chapel Hill, NC, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Samson%2BOkello%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Okello%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASamson%2BOkello%2B) Stephen Asiimwe 4 Massachusetts General Hospital (MGH), Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Stephen%2BAsiimwe%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Asiimwe%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AStephen%2BAsiimwe%2B) Deanna Saylor 9 University of North Carolina - Chapel Hill, Chapel Hill, NC, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Deanna%2BSaylor%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Saylor%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADeanna%2BSaylor%2B) Katherine L. Possin 10 Global Brain Health Institute (GBHI), University of California San Francisco (UCSF) * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Katherine%2BL.%2BPossin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Possin%20KL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKatherine%2BL.%2BPossin%2B) Elena Tsoy 10 Global Brain Health Institute (GBHI), University of California San Francisco (UCSF) * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elena%2BTsoy%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tsoy%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AElena%2BTsoy%2B) Mark J. Siedner 4 Massachusetts General Hospital (MGH), Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mark%2BJ.%2BSiedner%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Siedner%20MJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMark%2BJ.%2BSiedner%2B) Jeremy A. Tanner 1 Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jeremy%2BA.%2BTanner%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tanner%20JA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJeremy%2BA.%2BTanner%2B) * For correspondence: tannerj1@uthscsa.edu * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.21.26363152v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1306076/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.21.26363152v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1306076/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.21.26363152v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1306076/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.21.26363152v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1306076/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.21.26363152v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1306076/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Sub-Saharan Africa (sSA) faces accelerated growth in Alzheimer's disease and related dementias (ADRDs), including in older people living with HIV (PLWH). However, there are limited contextually relevant diagnostic tools to assess cognitive impairment in the region. The Tablet-based Cognitive Assessment Tool (TabCAT) is a digital platform hosting cognitive tests with automated scoring that can be administered by non-specialists and are designed for use across diverse cultures, languages, and education levels. We translated, adapted, and assessed the validity of a brief battery of TabCAT tests in the Uganda Aging and Dementia Cohort Study (UADCS), a prospective cohort of older PLWH and age- and sex-similar adults not living with HIV in southwestern Uganda. Methods: Four TabCAT tests were translated and culturally adapted through expert review and focus groups of adults at study sites. Psychometric validity was examined by assessing floor and ceiling effects, association with known demographic predictors, and concurrent and divergent validity against a reference-standard cognitive testing battery previously validated and employed in Uganda. Z-scores on all tests were derived using a regression-based normative approach to adjust for age, sex, education, urbanicity, and literacy. Receiver Operating Characteristic (ROC) curves were fit to assess the TabCAT Composite Score performance in discriminating objective cognitive impairment (defined using Jak/Bondi criteria) in the total sample, then stratified by HIV serostatus. Results: TabCAT tests were reported by local experts and focus groups to have acceptable face and content validity. Participants (n=563, mean age 60±6.4, 50% female, 51% did not complete primary school, 16% were not literate, 49% PLWH) completed the reference-standard and TabCAT battery. For TabCAT tests, there were no notable floor or ceiling effects, and test scores were associated with age and education as expected. Correlations between TabCAT and reference-standard tests were stronger in aligning cognitive domains (memory, executive function) than in non-aligning domains (motor). The TabCAT Composite Score discriminated cognitive impairment with good performance (c-statistic 0.77; 95% CI 0.72-0.81), including among PLWH. Discussion: TabCAT tests demonstrated face, content, construct, concurrent, and criterion validity for measuring cognition and detecting objective cognitive impairment among older adults in Uganda, including PLWH. These results support the potential of tablet-based brief cognitive assessment tools to measure cognitive performance and detect cognitive impairment in Uganda, including among older PLWH, and in populations with lower levels of education and literacy. ### Competing Interest Statement ACT reports receiving financial honoraria from Elsevier (for his work as Co-Editor in Chief of SSM — Mental Health) and BMJ Publishing Group Ltd. (for his work as Clinical Editorial Advisor of The BMJ). The other authors have no relevant financial or non-financial conflicts of interest to disclose. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical approval was obtained from Massachusetts General Hospital Institutional Review Board (IRB), the Mbarara University of Science and Technology Research Ethics Committee (MUSTREC), and the Uganda National Council for Science and Technology (UNCST). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, pleas
## Related Clinical Research

- [Ultra-processed foods linked to MRI signs of vascular brain injury in middle-aged adults](https://medichelpline.com/clinical-feed/medical-news-today-0-ultra-processed-foods-may-be-harming-brain-health-in-otherwise-healthy-adults.md)
- [Global dementia incidence projected to reach 24.7 million new cases annually by 2050](https://medichelpline.com/clinical-feed/medical-news-today-0-dementia-cases-to-double-by-2050-why-women-some-countries-may-be-at-higher-risk.md)
- [Bupropion Hydrochloride for Improving Recovery in Acute Ischaemic Stroke: BASE Trial Protocol](https://medichelpline.com/clinical-feed/bmj-open-4-protocol-for-base-a-multicentre-double-blind-randomised-controlled-trial-of.md)
- [Sensorimotor cortex beta activity during cued gait differs in Parkinson’s freezers and non-freezers](https://medichelpline.com/clinical-feed/medrxiv-2-sensorimotor-cortex-activity-during-cued-gait-differs-in-parkinson-s-freezers.md)
- [Designing Molecular Readers for Pathological PTM Proteoforms in Alzheimer’s Disease](https://medichelpline.com/clinical-feed/biorxiv-7-design-of-readers-for-pathological-ptm-proteoforms-in-alzheimer-s-disease.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.